Bladder cancer - Symptoms and causes - Mayo Clinic
网页2024年3月29日 · Bladder cancer is almost always one certain type of cancer called urothelial carcinoma, because it starts when urothelial cells that line the inside of the bladder over multiply and become abnormal. Most bladder cancer is caught in the early stages and therefore very treatable.
What Is Urothelial Carcinoma? - Cleveland Clinic
网页Urothelial carcinoma is cancer that starts in your urothelium, the tissue that lines parts of your urinary system. Urothelial carcinoma accounts for about 90% of all cases of bladder cancer and 7% of all cases of kidney cancer, including cancer in your renal pelvis and ureter.
What Is Bladder Cancer? | Types of Bladder Cancer
网页Urothelial carcinoma, also known as transitional cell carcinoma (TCC), starts in the urothelial cells that line the inside of the bladder. This is by far the most common type of bladder cancer. If you’re told you have bladder cancer, it's very likely to …
Bladder cancer - Diagnosis and treatment - Mayo Clinic
网页2024年3月29日 · The type of bladder cancer that most patients are diagnosed with is urothelial carcinoma. There are other types of cancers of the bladder, like adenocarcinomas and small cell carcinomas, but urothelial carcinoma is …
Urothelial carcinoma: 8 insights about this common bladder cancer
网页2024年5月24日 · Urothelial carcinoma is the most common type of bladder cancer. Here, genitourinary medical oncologist Omar Alhalabi, M.D., shares more about this disease, including symptoms, outlook and treatment advances.
What Is Bladder Cancer? - NCI - National Cancer Institute
网页2023年2月16日 · Urothelial carcinoma (also called transitional cell carcinoma) is cancer that begins in the urothelial cells, which line the urethra, bladder, ureters, renal pelvis, and some other organs. Almost all bladder cancers are urothelial carcinomas.
Clinical presentation, diagnosis, and staging of bladder cancer
网页2024年1月31日 · Bladder cancer is the most common malignancy involving the urinary system. Urothelial (transitional cell) carcinoma is the predominant histologic type in the United States and Europe, where it accounts for 90 percent of all bladder cancers. In other areas of the world, non-urothelial carcinomas are more frequent.
Proteogenomics of different urothelial bladder cancer stages …
网页2023年9月13日 · Proteogenomic integration analysis indicates the mutations of HRAS regulated mTOR signaling to form urothelial papilloma rather than papillary urothelial cancer (PUC). DNA damage is a key ...
Non—muscle-invasive Bladder Cancer: Overview and …
网页Non—muscle-invasive bladder cancer (NMIBC) is a heterogeneous subclassification of urothelial carcinoma with significant variation in individual risk of recurrence and progression to muscle-invasive disease.
Advances in bladder cancer biology and therapy - Nature
网页2020年12月2日 · Urothelial carcinoma of the bladder is comprised of two major groups on the basis of clinical staging with different clinical outcomes and therapy options: non-muscle-invasive bladder cancer...